Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study

被引：62

作者：

Huang, Jiaqi ^{[1
]}

Zagai, Ulrika ^{[1
]}

Hallmans, Goran ^{[2
]}

Nyren, Olof ^{[1
]}

Engstrand, Lars ^{[3
]}

Stolzenberg-Solomon, Rachael ^{[4
]}

Duell, Eric J. ^{[5
]}

Overvad, Kim ^{[6
]}

Katzke, Verena A. ^{[7
]}

Kaaks, Rudolf ^{[7
]}

Jenab, Mazda ^{[8
]}

Park, Jin Young ^{[8
]}

Murillo, Raul ^{[8
]}

Trichopoulou, Antonia ^{[9
,10
]}

Lagiou, Pagona ^{[9
,10
,11
]}

Bamia, Christina ^{[9
,10
]}

Bradbury, Kathryn E. ^{[12
]}

Riboli, Elio ^{[13
]}

Aune, Dagfinn ^{[13
]}

Tsilidis, Konstantinos K. ^{[13
,24
]}

Capella, Gabriel ^{[14
]}

Agudo, Antonio ^{[15
]}

Krogh, Vittorio ^{[16
]}

Palli, Domenico ^{[17
]}

Panico, Salvatore ^{[18
]}

Weiderpass, Elisabete ^{[1
,19
,20
,21
]}

Tjonneland, Anne ^{[22
]}

Olsen, Anja ^{[22
]}

Martinez, Begona ^{[23
]}

Redondo-Sanchez, Daniel ^{[23
,26
,40
]}

Chirlaque, Maria-Dolores ^{[25
,26
,27
]}

Peeters, Petra Hm ^{[28
]}

Regner, Sara ^{[29
]}

Lindkvist, Bjorn ^{[30
]}

Naccarati, Alessio ^{[31
]}

Ardanaz, Eva ^{[26
,32
,33
]}

Larranaga, Nerea ^{[26
]}

Boutron-Ruault, Marie-Christine ^{[34
,35
,36
]}

Rebours, Vinciane ^{[37
]}

Barre, Amelie ^{[38
,39
]}

Bueno-de-Mesquita, H. B ^{[41
,42
,43
,44
]}

Ye, Weimin ^{[1
,45
]}

机构：

[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Solna, Sweden

[2] Umea Univ, Dept Publ Hlth & Clin Nutr, Umea, Sweden

[3] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden

[4] NCI, Metab Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA

[5] Catalan Inst Oncol ICO IDIBELL, Unit Nutr & Canc, Canc Epidemiol Res Program, Barcelona, Spain

[6] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark

[7] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

[8] Int Agcy Res Canc, Sect Nutr & Metab, Sect Early Detect & Prevent, Prevent & Implementat Grp, Lyon, France

[9] Hellen Hlth Fdn, Athens, Greece

[10] Natl & Kapodistrian Univ Athens, WHO Collaborating Ctr Nutr & Hlth, Sch Med, Unit Nutr Epidemiol & Nutr Publ Hlth,Dept Hyg Epi, Athens, Greece

[11] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA

[12] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England

[13] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England

[14] IDIBELL Catalan Inst Oncol, Translat Res Lab, Barcelona, Spain

[15] Catalan Inst Oncol IDIBELL, Canc Epidemiol Res Program, Unit Nutr & Canc, Barcelona, Spain

[16] Fdn IRCCS Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy

[17] Canc Res & Prevent Inst ISPO, Canc Risk Factors & Life Style Epidemiol Unit, Florence, Italy

[18] Dipartimento Med Clin & Chirurg Federico II, Naples, Italy

[19] Arctic Univ Norway, Univ Tromso, Dept Community Med, Tromso, Norway

[20] Inst Populat Based Canc Res, Canc Registry Norway, Dept Res, Oslo, Norway

[21] Folkhalsan Res Ctr, Genet Epidemiol Grp, Helsinki, Finland

[22] Danish Canc Soc, Res Ctr, Copenhagen, Denmark

[23] Inst Invest Biosanitaria Ibs, Andalusian Sch Publ Hlth, Granada, Spain

[24] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Ioannina, Greece

[25] IMIB Arrixaca, Reg Hlth Council, Dept Epidemiol, Murcia, Spain

[26] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain

[27] Univ Murcia, Dept Hlth & Social Sci, Murcia, Spain

[28] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands

[29] Lund Univ, Inst Clin Sci Malmo, Dept Surg, Malmo, Sweden

[30] Sahlgrens Univ Hosp, Dept Med, Gothenburg, Sweden

[31] Human Genet Fdn, Mol & Genet Epidemiol Unit, Turin, Italy

[32] Navarra Publ Hlth Inst, Pamplona, Spain

[33] Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain

[34] Ctr Res Epidemiol & Populat Hlth CESP, Hormones & Womens Hlth Team, INSERM, U1018,Nutr, F-94805 Villejuif, France

[35] Univ Paris Sud, UMRS 1018, F-94805 Villejuif, France

[36] Inst Gustave Roussy, F-94805 Villejuif, France

[37] Univ Paris 07, Beaujon Hosp, Dept Gastroenterol & Pancreatol, Clichy, France

[38] Univ Paris Sud, Le Kremlin Bicetre, France

[39] CHU Bicetre, Hop Univ Paris Sud, AP HP, Gastroenterol Unit, Le Kremlin Bicetre, France

[40] Univ Granada, Hosp Univ Granada, Inst Invest Biosanitaria Ibs, Escuela Andaluza Salud Publ, Granada, Spain

[41] Natl Inst Publ Hlth & Environm RIVM, Dept Determinants Chron Dis DCD, Bilthoven, Netherlands

[42] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands

[43] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England

[44] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia

[45] Umea Univ, Med Biobank, Umea, Sweden

来源：

INTERNATIONAL JOURNAL OF CANCER | 2017年 / 140卷 / 08期

基金：

英国医学研究理事会;

关键词：

H. pylori infection; chronic corpus atrophic gastritis; pancreatic cancer risk; nested case-control study; EPIC cohort; ABO BLOOD-GROUP; SEROPOSITIVITY; CAGA; EPIDEMIOLOGY; METAANALYSIS; ASSOCIATION; POPULATION; STATISTICS;

D O I：

10.1002/ijc.30590

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

The association between H. pylori infection and pancreatic cancer risk remains controversial. We conducted a nested case-control study with 448 pancreatic cancer cases and their individually matched control subjects, based on the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, to determine whether there was an altered pancreatic cancer risk associated with H. pylori infection and chronic corpus atrophic gastritis. Conditional logistic regression models were applied to calculate odds ratios (ORs) and corresponding 95% confidence intervals (CIs), adjusted for matching factors and other potential confounders. Our results showed that pancreatic cancer risk was neither associated with H. pylori seropositivity (OR = 0.96; 95% CI: 0.70, 1.31) nor CagA seropositivity (OR = 1.07; 95% CI: 0.77, 1.48). We also did not find any excess risk among individuals seropositive for H. pylori but seronegative for CagA, compared with the group seronegative for both antibodies (OR = 0.94; 95% CI: 0.63, 1.38). However, we found that chronic corpus atrophic gastritis was non-significantly associated with an increased pancreatic cancer risk (OR = 1.35; 95% CI: 0.77, 2.37), and although based on small numbers, the excess risk was particularly marked among individuals seronegative for both H. pylori and CagA (OR = 5.66; 95% CI: 1.59, 20.19, p value for interaction < 0.01). Our findings provided evidence supporting the null association between H. pylori infection and pancreatic cancer risk in western European populations. However, the suggested association between chronic corpus atrophic gastritis and pancreatic cancer risk warrants independent verification in future studies, and, if confirmed, further studies on the underlying mechanisms.

引用

页码：1727 / 1735

页数：9

共 41 条

[1]

Anderson K.E., 1996, CANC EPIDEMIOLOGY PR, V2nd, P725

[2]

[Anonymous], EUR J CANC IN PRESS

[3]

INCREASED INCIDENCE OF PANCREATIC NEOPLASIA IN PERNICIOUS-ANEMIA [J].

BORCH, K ;

KULLMAN, E ;

HALLHAGEN, S ;

LEDIN, T ;

IHSE, I .

WORLD JOURNAL OF SURGERY, 1988, 12 (06) :866-870

[4]

CORREA P, 1992, CANCER RES, V52, P6735

[5]

Helicobacter pylori infection and development of pancreatic cancer [J].

de Martel, Catherine ;

Llosa, Augusto E. ;

Friedmana, Gary D. ;

Vogelman, Joseph H. ;

Orentreich, Norman ;

Stolzenberg-Solomon, Rachael Z. ;

Parsonnet, Julie .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (05) :1188-1194

[6]

Epidemiology of premalignant gastric lesions: Implications for the development of screening and surveillance strategies [J].

de Vries, Annemarie C. ;

Kulpers, Ernst J. .

HELICOBACTER, 2007, 12 :22-31

[7]

Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population [J].

Duell, Eric J. ;

Bonet, Catalina ;

Munoz, Xavier ;

Lujan-Barroso, Leila ;

Weiderpass, Elisabete ;

Boutron-Ruault, Marie-Christine ;

Racine, Antoine ;

Severi, Gianluca ;

Canzian, Federico ;

Rizzato, Cosmeri ;

Boeing, Heiner ;

Overvad, Kim ;

Tjonneland, Anne ;

Argueelles, Marcial ;

Sanchez-Cantalejo, Emilio ;

Chamosa, Saioa ;

Maria Huerta, Jose ;

Barricarte, Aurelio ;

Khaw, Kay-Tee ;

Wareham, Nick ;

Travis, Rutch C. ;

Trichopoulou, Antonia ;

Trichopoulos, Dimitrios ;

Yiannakouris, Nikos ;

Palli, Domenico ;

Agnoli, Claudia ;

Tumino, Rosario ;

Naccarati, Alessio ;

Panico, Salvatore ;

Bueno-de-Mesquita, H. B ;

Siersema, Peter D. ;

Peeters, Petra H. M. ;

Ohlsson, Bodil ;

Lindkvist, Bjorn ;

Johansson, Ingegerd ;

Ye, Weimin ;

Johansson, Matthias ;

Fenger, Claus ;

Riboli, Elio ;

Sala, Nuria ;

Gonzalez, Carlos A. .

INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (04) :880-893

[8]

Gastritis and gastric atrophy [J].

El-Zimaity, Hala .

CURRENT OPINION IN GASTROENTEROLOGY, 2008, 24 (06) :682-686

[9]

Analysis of mortality rates for pancreatic cancer across the world [J].

Hariharan, D. ;

Saied, A. ;

Kocher, H. M. .

HPB, 2008, 10 (01) :58-62

[10]

BACTERIA IN THE AETIO-PATHOGENESIS OF GASTRIC-CANCER - A REVIEW [J].

HOUBEN, GMP ;

STOCKBRUGGER, RW .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 :13-18

← 1 2 3 4 5 →